Skip to main content

Table 1 Study procedure of enrolment, allocation, and outcome assessments

From: Clinical efficacy of Yukgunja-tang combined with a proton pump inhibitor for refractory gastroesophageal reflux disease: study protocol for randomized, double-blind, double-dummy clinical trial

  1. GERD Gastroesophageal reflux disease